Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
Anticancer Research
|
January 19, 1999
Nm23-H1 protein, DNA-ploidy and S-phase fraction in relation to overall survival and disease free survival in transitional cell carcinoma of the bladder
M Alderisio, M Cenci, C Valli, et al.
International Journal of Oncology
|
May 12, 2011
P53 expression in stage iii-iv squamous-cell carcinoma of the larynx - an immunohistochemical study related to clinicopathological, flow-cytometric DNA analysis and prognosis
R Tomasino, V Morello, V Bazan, et al.
Cell Proliferation
|
December 16, 1998
Prognostic significance of proliferative activity, DNA-ploidy, p53 and Ki-ras point mutations in colorectal liver metastases
A Russo, M Migliavacca, V Bazan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 28, 2002
Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype
V Bazan, M Migliavacca, I Zanna, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 1, 2005
Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study
V Bazan, V Agnese, S Corsale, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2000
Prognostic significance of DNA ploidy, S-phase fraction, and tissue levels of aspartic, cysteine, and serine proteases in operable gastric carcinoma
A Russo, V Bazan, M Migliavacca, et al.
Cancer
|
July 24, 2001
DNA aneuploidy and high proliferative activity but not K-ras-2 mutations as independent predictors of clinical outcome in operable gastric carcinoma: results of a 5-year Gruppo Oncologico dell'Italia Meridonale (GDIM) prospective study
A Russo, V Bazan, M Migliavacca, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 9, 2006
Molecular detection of TP53, Ki-Ras and p16INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis. Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study
V Bazan, L Bruno, C Augello, et al.
Journal of Cancer Research and Clinical Oncology
|
December 11, 2002
DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study
V Bazan, M Migliavacca, I Zanna, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 10, 2006
Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study
B Iacopetta, A Russo, V Bazan, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
Anticancer Research
|
January 19, 1999
Nm23-H1 protein, DNA-ploidy and S-phase fraction in relation to overall survival and disease free survival in transitional cell carcinoma of the bladder
M Alderisio, M Cenci, C Valli, et al.
International Journal of Oncology
|
May 12, 2011
P53 expression in stage iii-iv squamous-cell carcinoma of the larynx - an immunohistochemical study related to clinicopathological, flow-cytometric DNA analysis and prognosis
R Tomasino, V Morello, V Bazan, et al.
Cell Proliferation
|
December 16, 1998
Prognostic significance of proliferative activity, DNA-ploidy, p53 and Ki-ras point mutations in colorectal liver metastases
A Russo, M Migliavacca, V Bazan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 28, 2002
Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype
V Bazan, M Migliavacca, I Zanna, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 1, 2005
Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study
V Bazan, V Agnese, S Corsale, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2000
Prognostic significance of DNA ploidy, S-phase fraction, and tissue levels of aspartic, cysteine, and serine proteases in operable gastric carcinoma
A Russo, V Bazan, M Migliavacca, et al.
Cancer
|
July 24, 2001
DNA aneuploidy and high proliferative activity but not K-ras-2 mutations as independent predictors of clinical outcome in operable gastric carcinoma: results of a 5-year Gruppo Oncologico dell'Italia Meridonale (GDIM) prospective study
A Russo, V Bazan, M Migliavacca, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 9, 2006
Molecular detection of TP53, Ki-Ras and p16INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis. Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study
V Bazan, L Bruno, C Augello, et al.
Journal of Cancer Research and Clinical Oncology
|
December 11, 2002
DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study
V Bazan, M Migliavacca, I Zanna, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 10, 2006
Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study
B Iacopetta, A Russo, V Bazan, et al.
Page
of 5